Cardiology Research Dubrava: Single Centre, Prospective Registry
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
Cardiology Research Dubrava registry is a prospective, single centre registry including patients with acute coronary syndrome with and without ST segment elevation, patients with heart failure who were prescribed with SGLT-2 inhibitors, patients implanted with TAVI, patients with venous thromboembolism, patients with pulmonary embolism who underwent thromboaspiration procedure, patients implanted with ICD, CRT and conduction system pacing devices, as well as patients with atrial fibrillation who underwent pulmonary vein isolation and are prescribed with long-term anticoagulation therapy.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
Locations
Other Locations
Croatia
Dubrava University Hospital
RECRUITING
Zagreb
Contact Information
Primary
Ivan Zeljkovic, M.D.
kardio@kbd.hr
00385917823289
Backup
Ivana Jurin, M.D.
ivanajurin1912@gmail.com
Time Frame
Start Date: 2023-01-01
Estimated Completion Date: 2033-06
Participants
Target number of participants: 3000
Treatments
Acute coronary syndrome - ACS
patients who were diagnosed with acute coronary syndrome: STEMI, non-STE ACS - NSTEMI and unstable angina, who underwent coronary angiography and were prescribed with optimal medicament therapy
Transcatheter aortic valve implantation - TAVI
patients with aortic stenosis who underwent transcatheter percotaneous implantation of the arteficial aortic valve
Venous thromboembolism - VTE
patients with pulmonary embolism and deep vein thrombosis, with a focus on those who underwent thromboaspiration due to high or medium-high risk pulmonary embolism
Heart failure with SGLT2 inhibitor therapy included - HF-SGLT2
patients with heart failure with reduced, mid-reduced and preserved systolic function who were prescribed with a SGLT-2 inhibitor therapy, and other optimal medicament therapy for HF
Cardiac implantable electronic device - CIED
patients who were implanted with a cardiac implantable electronic device: pacemaker, conduction system pacing device, cardioverter-defibrilator or cardiac resynchronization therapy with or without defibrilator option
Arrhythmias
patients who underwent electrophysiology study, including PVI for atrial fibrillation, as well as SVT ablations, and ventricular arrhythmia ablation (both premature ventriclar beats and ventricular tachycardia ablation in ischsmic and non-ischemic cardiomyopathy).
Related Therapeutic Areas
Sponsors
Leads: University Hospital Dubrava